Quantitative metabolomics services for biomarker discovery and validation.
Specializing in ready to use metabolomics kits.
Your source for quantitative metabolomics technologies and bioinformatics.
Loader

Filter by Species:

Filter by Pathway Type:

Select Pathway Sub-Category:

Select Pathway Sub-Category:


Search for '28cortisol oh aldosterone 20 and subjected 3ametabolic' in 'all pathways' in 'all' returned 517568 results

SMP0531593

Pw560516 View Pathway
Metabolite

Methylglyoxal Degradation II

Barnesiella intestinihominis YIT 11860

  • Matched Description: stationary phase and expression is dependent on RpoS, suggesting that this pathway may be important during stationary phase. (EcoCyc)

  • Metabolic

    SMP0530264

    Pw558908 View Pathway
    Metabolite

    Methylglyoxal Degradation II

    Bacteroides intestinalis

  • Matched Description: stationary phase and expression is dependent on RpoS, suggesting that this pathway may be important during stationary phase. (EcoCyc)

  • Metabolic

    SMP0532123

    Pw561184 View Pathway
    Metabolite

    Methylglyoxal Degradation II

    Lautropia mirabilis ATCC 51599

  • Matched Description: stationary phase and expression is dependent on RpoS, suggesting that this pathway may be important during stationary phase. (EcoCyc)

  • Metabolic

    SMP0529989

    Pw558585 View Pathway
    Metabolite

    Methylglyoxal Degradation II

    Bacteroides stercoris ATCC 43183

  • Matched Description: stationary phase and expression is dependent on RpoS, suggesting that this pathway may be important during stationary phase. (EcoCyc)

  • Metabolic

    SMP0000292

    Pw000360 View Pathway
    Metabolite

    Minocycline Action Pathway

    Homo sapiens

  • Matched Description: synthesis will be inihibited which lead to inhitation of further growth and colonization of bacteria.

  • Drug Action

    SMP0130470

    Pw132089 View Pathway
    Metabolite

    Plasminogen

    Mus musculus

  • Matched Description: that degrades fibrin clots. In addition to its binding and activation on fibrin clots, PLG also … present in humans - type I plasminogen contains two glycosylation moieties (N-linked to N289 and O … , including tissue plasminogen activator (tPA), urokinase plasminogen activator (uPA), kallikrein, and … urokinase plasminogen activator. The conversion of plasminogen to plasmin involves the cleavage of the peptide bond between Arg-561 and Val-562.

  • Physiological

    SMP0130472

    Pw132091 View Pathway
    Metabolite

    Plasminogen

    Bos taurus

  • Matched Description: that degrades fibrin clots. In addition to its binding and activation on fibrin clots, PLG also … present in humans - type I plasminogen contains two glycosylation moieties (N-linked to N289 and O … , including tissue plasminogen activator (tPA), urokinase plasminogen activator (uPA), kallikrein, and … urokinase plasminogen activator. The conversion of plasminogen to plasmin involves the cleavage of the peptide bond between Arg-561 and Val-562.

  • Physiological

    SMP0124484

    Pw125964 View Pathway
    Metabolite

    Spectinomycin Anti-bacterial Action Pathway

    Homo sapiens

  • Matched Description: interferes with the initiation of protein synthesis and with proper protein elongation. This eventually leads to bacterial cell death.

  • Drug Action

    SMP0126633

    Pw128235 View Pathway
    Metabolite

    Apomorphine Mechanism of Action Action Pathway

    Homo sapiens

  • Matched Description: Apomorphine is a non-ergoline dopamine agonist with high binding affinity to dopamine D2, D3, and

  • Drug Action

    SMP0089751

    Pw090771 View Pathway
    Metabolite

    Bile Acid Direct Signalling Pathway (2)

    Homo sapiens

  • Matched Description: can enter the systemic cirulation, and most of GLP-1 are degraded by dipeptidyl peptidase-4

  • Signaling